Abstract
Memantine, a clinically used NMDA receptor antagonist possesses neuroprotective properties, but the exact mechanisms of its beneficial action on neuronal survival are poorly recognized. In the present study, some intracellular mechanisms of memantine effects on staurosporine-evoked cell death were investigated in primary cortical neurons. Memantine (0.1–2 μM) suppressed neuronal apoptosis evoked by staurosporine in 7 DIV cortical neurons, whereas other antagonists of NMDA receptor, MK-801 (1 μM) and AP-5 (100 μM) were ineffective. The anti-apoptotic effects of memantine were not connected with any changes in cytoplasmic calcium concentration or reactive oxygen species level. The immunoblot analysis showed that the staurosporine induced a decrease in p-Akt protein kinase level and that this effect was reversed by memantine treatment. Moreover, the PI3-K inhibitors, wortmannin and LY 294002 attenuated the anti-apoptotic action of memantine on staurosporine-induced cell damage. Furthermore, the ELISA studies showed increased cellular and released BDNF protein level after combined treatment with memantine and staurosporine. There was no effect of memantine on the activation and expression of other protein kinases involved in the mechanism of cellular survival, i.e. ERK1/2, JNK and GSK3-β. The obtained data suggest an NMDAR-independent action of memantine in attenuation of neuronal apoptosis and point to the engagement of BDNF and PI3-K/Akt pathway in these processes.
Similar content being viewed by others
Abbreviations
- Akt:
-
Protein kinase Akt, protein kinase B
- AP-5:
-
2-Amino-5-phosphopentanoic acid
- BDNF:
-
Brain-derived neurotrophic factor
- CREB:
-
cAMP response element-binding protein
- DIV:
-
Day in vitro
- ERK1/2:
-
Extracellularly regulated protein kinase 1/2
- GSK3-β:
-
Glycogen synthase kinase 3-β
- JC-1:
-
5′,6,6′-Tetrachloro-1,1,3,3′-tetraethylbenzimidazolcarbocyanine iodide
- JNK:
-
c-Jun NH(2)-terminal kinase
- LDH:
-
Lactate dehydrogenase
- MAPK:
-
Mitogen-activated protein kinase
- MMP:
-
Mitochondrial membrane potential
- MTT:
-
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
- NMDA:
-
N-Methyl-d-aspartic acid
- PI3-K:
-
Phosphatidylinositol-3 kinase
- St:
-
Staurosporine
References
Muller WE, Schroder HC, Ushijima H, Dapper J, Bormann J (1992) gp120 of HIV-1 induced apoptosis in rat cortical cell cultures: prevention by memantine. Eur J Pharmacol 226:209–214
Muller WE, Pergande G, Ushijima H, Schleger C, Kelve M, Perovic S (1996) Neurotoxicity in rat cortical cells caused by N-methyl-d-aspartate (NMDA) and gp120 of HIV: induction and pharmacological intervention. Prog Mol Subcell Biol 16:44–57
Muller WE, Laplanche JL, Ushijima H, Schroder HC (2000) Novel approaches in diagnosis and therapy of Creutzfeldt-Jakob disease. Mech Agening Dev 116:193–218
Parson CG, Danysz W, Quack G (1999) Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist–a review of preclinical data. Neuropharmacology 38:735–767
Miguel-Hidalgo JJ, Alvarez XA, Cacabelos R, Quack G (2002) Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1–40). Brain Res 958:210–221
Lipton SA (2004) Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults. NeuroRx 1:101–110
Lipton SA (2005) The molecular basis of memantine action in Alzheimer’s disease and other neurologic disorders: low-affinity, uncompetitive antagonism. Curr Alzheimer Res 2:155–165
Wenk GL, Parson CG, Danysz W (2006) Potential role of N-methyl -d-aspartate receptors as executors of neurodegeneration resulting from diverse insults: focus on memantine. Behav Pharmacol 17:411–424
Volbracht C, van Beek J, Zhu C, Blomgren K, Leist M (2006) Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity. Eur J NeuroSci 23:2611–2622
Tozzi A, Costa C, Di Filippo M, Tantucci M, Siliquini S, Belcastro V, Parnetti L, Picconi B, Calabresi P (2007) Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. Exp Neurol 207:218–226
Chipana C, Torres I, Camarasa J, Pubill D, Escubedo E (2008) Memantine protects against amphetamine derivatives-induced neurotoxic damage in rodents. Neuropharmacology 54:1254–1263
Jantas D, Pytel M, Mozrzymas JW, Leskiewicz M, Regulska M, Antkiewicz-Michaluk L, Lason W (2008) The attenuating effect of memantine on staurosporine-, salsolinol- and doxorubicin-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurochem Int 52:864–877
Parsons CG, Gilling KE, Jatzke C (2008) Memantine does not show intracellular block of the NMDA receptor channel. Eur J Pharmacol 587:99–103
Song MS, Rauw G, Baker GB, Kar S (2008) Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation. Eur J NeuroSci 28:1989–2002
Rammes G, Rupprecht R, Ferrari U, Zieglgänsberger W, Parsons CG (2001) The NMDA receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes also antagonise 5HT3 receptor currents in HEK-293 and N1E–115 cells in a non-competitive manner. Neurosci Lett 306:81–84
Ovalle S, Andreu F, Perez MP, Zamanillo D, Guitart X (2002) Effect of the novel sigma1 receptor ligand and putative antipsychotic E-5842 on BDNF mRNA expression in the rat brain. NeuroReport 13:2345–2348
Peeters M, Romieu P, Maurice T, Su TP, Maloteaux JM, Hermans E (2004) Involvement of the sigma 1 receptor in the modulation of dopaminergic transmission by amantadine. Eur J NeuroSci 19:2212–2220
Aracava Y, Pereira EF, Maelicke A, Albuquerque EX (2005) Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than N-methyl-d-aspartate receptors in rat hippocampal neurons. J Pharmacol Exp Ther 312:1195–1205
Chipana C, Camarasa J, Pubill D, Escubedo E (2008) Memantine prevents MDMA-induced neurotoxicity. Neurotoxicology 29:179–183
Jantas-Skotniczna D, Kajta M, Lason W (2006) Memantine attenuates staurosporine-induced activation of caspase-3 and LDH release in mouse primary neuronal cultures. Brain Res 1069:145–153
Kajta M, Trotter A, Lasoń W, Beyer C (2005) Effect of NMDA on staurosporine-induced activation of caspase-3 and LDH release in mouse neocortical and hippocampal cells. Brain Res Dev Brain Res 160:40–52
Williams K, Russell SL, Shen YM, Molinoff PB (1993) Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro. Neuron 10:267–278
Prehn JHM, Jordan J, Ghadge GD, Preis E, Galindo MF, Roos RP, Krieglstein J, Miller RJ (1997) Ca2+ and reactive oxygen species in staurosporine-induced neuronal apoptosis. J Neurochem 68:1679–1685
Osakada F, Hashino A, Kume T, Katsuki H, Kaneko S, Akaike A (2004) α-Tocotrienol provides the most potent neuroprotection among vitamin E analogs on cultured striatal neurons. Neuropharmacology 47:904–915
Lupp A, Kerst S, Karge E (2003) Evaluation of possible pro- or antioxidative properites and of the interaction capacity with the microsomal cytochrome P450 system of different NMDA-receptor ligands and of taurine in vitro. Exp Toxicol Pathol 54:441–448
Marvanova M, Lakso M, Pirhonen J, Nawa H, Wong G, Castren E (2001) The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain. Mol Cell Neurosci 18:247–258
Meisner F, Scheller C, Kneitz S, Sopper S, Neuen-Jacob E, Riederer P, Meulen VT, Koutsilieri E (2007) Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine. Neuropsychopharmacology 33:2228–2236
Brewer GJ (1995) Serum-free B27/neurobasal medium supports differentiated growth of neurones from the striatum, substantia nigra, septum, cerebral cortex, cerebellum and dentate gyrus. J Neurosci Res 42:674–683
Jantas D, Lason W (2009) Protective effect of memantine against doxorubicin toxicity in primary neuronal cell cultures: influence a development stage. Neurotox Res 15:24–37. doi:10.1007/s12640-009-9002-8
Wang H, Joseph JA (1999) Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med 27:612–616
Hemstapat K, Smith MT, Monteith GR (2004) Measurement of intracellular Ca2 + in cultured rat embryonic hippocampal neurons using a fluorescence microplate reader: potential application to biomolecular screening. J Pharmacol Toxicol Methods 49:81–87
Balkowiec A, Katz DM (2000) Activity-dependent release of endogenous brain-derived neurotrophic factor from primary sensory neurons detected by ELISA in situ. J Neurosci 20:7417–7423
Budd SL, Tenneti L, Lishnak T, Lipton SA (2000) Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. Proc Natl Acad Sci USA 97:6161–6166
Williams AJ, Dave JR, Lu XM, Ling L, Tortella FC (2002) Selective NR2B NMDA receptor antagonist are protective against staurosporine-induced apoptosis. Eur J Pharmacol 452:135–136
Dave JR, Williams AJ, Moffett JR, Koenig ML, Tortella FC (2003) Studies of neuronal apoptosis in primary forebrain cultures: neuroprotective/anti-apoptotic action of NR2B NMDA antagonists. Neurotox Res 5:255–264
Church J, Shacklock JA, Baimbridge KG (1991) Dextromethorphan and phencyclidine receptor ligands: differential effects on K(+)- and NMDA-evoked increases in cytosolic free Ca2+ concentration. Neurosci Lett 124:232–234
Csernansky CA, Canzoniero LM, Sensi SL, Yu SP, Choi DW (1994) Delayed application of aurintricarboxylic acid reduces glutamate-induced cortical neuronal injury. J Neurosci Res 38:101–108
Reynolds IJ, Hastings TG (1995) Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J Neurosci 5:3318–3327
Zhu Y, Hoell P, Ahlemeyer B, Krieglstein J (2006) PTEN: a crucial mediator of mitochondria-dependent apoptosis. Apoptosis 11:197–207
Krohn AJ, Wahlbrink T, Prehn JH (1999) Mitochondrial depolarization is not required for neuronal apoptosis. J Neurosci 19:7394–7404
Brunet A, Datta SR, Greenberg ME (2001) Transcription-dependent and -independent control of neuronal survival by the PI3 K-Akt signaling pathway. Curr Opin Neurobiol 11:297–305
Hetman M, Gozdz A (2004) Role of extracellular signal regulated kinases 1 and 2 in neuronal survival. Eur J Biochem 271:2050–2055
Papadia S, Soriano FX, Léveillé F, Martel MA, Dakin KA, Hansen HH, Kaindl A, Sifringer M, Fowler J, Stefovska V, McKenzie G, Craigon M, Corriveau R, Ghazal P, Horsburgh K, Yankner BA, Wyllie DJ, Ikonomidou C, Hardingham GE (2008) Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat Neurosci 11:476–487
Lipton SA (2006) Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat Rev Drug Discov 5:160–170
Hardingham GE, Fukunaga Y, Bading H (2002) Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci 5:405–414
Hardingham GE, Bading H (2002) Coupling of extrasynaptic NMDA receptors to a CREB shut-off pathway is developmentally regulated. Biochim Biophys Acta 1600:148–153
Zhu Y, Hoell P, Ahlemeyer B, Sure U, Bertalanffy H, Krieglstein J (2007) Implication of PTEN in production of reactive oxygen species and neuronal death in in vitro models of stroke and Parkinson’s disease. Neurochem Int 50:507–516
Hetman M, Xia Z (2000) Signaling pathways mediating anti-apoptotic action of neurotrophins. Acta Neurobiol Exp (Wars) 60:531–545
Kharebava G, Makonchuk D, Kalita KB, Zheng JJ, Hetman M (2008) Requirement of 3-phosphoinositide-dependent protein kinase-1 for BDNF-mediated neuronal survival. J Neurosci 28:11409–11420
Hetman M, Kanning K, Cavanaugh JE, Xia Z (1999) Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J Biol Chem 274:22569–22580
Klumpp S, Kriha D, Bechmann G, Maassen A, Maier S, Pallast S, Hoell P, Krieglstein J (2006) Phosphorylation of the growth factors bFGF, NGF and BDNF: a prerequisite for their biological activity. Neurochem Int 48:131–137
Nguyen N, Lee SB, Lee YS, Lee KH, Ahn JY (2008) Neuroprotection by NGF and BDNF against neurotoxin-exerted apoptotic death in neural stem cells are mediated through Trk receptors, activating PI3-kinase and MAPK pathways. Neurochem Res 1:20 [Epub ahead of print]
Luo HR, Hattori H, Hossain MA, Hester L, Huang Y, Lee-Kwon W, Donowitz M, Nagata E, Snyder SH (2003) Akt as a mediator of cell death. Proc Natl Acad Sci USA 100:11712–11717
Chin PC, Majdzadeh N, D’Mello SR (2005) Inhibition of GSK3beta is a common event in neuroprotection by different survival factors. Brain Res Mol Brain Res 137:193–201
De Sarno P, Bijur GN, Zmijewska AA, Li X, Jope RS (2006) In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors. Neurobiol Aging 27:413–422
Yuan J, Yankner BA (2000) Apoptosis in the nervous system. Nature 407:802–809
Lee ST, Chu K, Park JE, Kang L, Ko SY, Jung KH, Kim M (2006) Memantine reduces striatal cell death with decreasing calpain level in 3-nitropropionic model of Huntington’s disease. Brain Res 1118:199–207
Zhu Y, Yang GY, Ahlemeyer B, Pang L, Che XM, Culmsee C, Klumpp S, Krieglstein J (2002) Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. J Neurosci 22:3898–3909
Chen Q, Cui J, Zhang Y, Yu LC (2008) Prolonged morphine application modulates Bax and Hsp70 levels in primary rat neurons. Neurosci Lett 441:311–314
Chen YR, Tan TH (2000) The c-Jun N-terminal kinase pathway and apoptotic signaling (review). Int J Oncol 16:651–662
Acknowledgments
The study was supported by grant No. 1874/P01/2006/31 from the State Committee for Scientific Research, Warsaw, Poland. We kindly thank Ms Barbara Korzeniak for her excellent technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jantas, D., Szymanska, M., Budziszewska, B. et al. An involvement of BDNF and PI3-K/Akt in the anti-apoptotic effect of memantine on staurosporine-evoked cell death in primary cortical neurons. Apoptosis 14, 900–912 (2009). https://doi.org/10.1007/s10495-009-0370-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10495-009-0370-6